Project Number 5R01AG031221-05 Agency/Funding Organization NIA Funding Year 2012 View Full Project Details for TARGETING THE APOE/ABETA INTERACTION AS A NOVEL AD THERAPY Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) c. ApoE, Lipids and Lipoprotein Receptors Researcher and Organization Principal Investigator SADOWSKI, MARTIN JOSEPH Principal Investigator First Name MARTIN JOSEPH Principal Investigator Last Name SADOWSKI Awardee Organization NEW YORK UNIVERSITY SCHOOL OF MEDICINE Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-06-479: TARGETING DISEASES CAUSED BY PROTEIN MISFOLDING OR MISPROCESSING FY Overall Cost $327,045 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official BUCKHOLTZ, NEIL Related Resources Repository [AlzPED] APOE Genotype Differentially Modulates Effects of Anti-Aβ, Passive Immunization in APP Transgenic Mice Patent Peptoid and synthetic oligomers| pharmaceutical compositions and methods of using same Pyridyl-2-methylamino compounds| compositions and uses thereof Treatment of Alzheimer amyloid deposition
